The first cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection were reported in December 2019, triggering a global health crisis with a coronavirus pandemic-19 (COVID-19). Fever, a dry cough, and shortness of breath are the most common symptoms. GI symptoms, on the other hand, have been found to be an essential clinical finding in the course of the disease. Furthermore, though the pathophysiology of these symptoms is still being researched, the relationship between SARS-CoV-2 and Angiotensin-Converting Enzyme type 2 (ACE2), which is expressed in both the respiratory and gastrointestinal systems, is implicated in viral pathogenesis as a key clinical finding in the progression of the disease. Gastrointestinal manifestations of disease has turned out to be a distinct entity and there is a need to update ourself on this issue as we need high index of suspicion to rule out this infection when patients initially present with gastrointestinal manifestations.